A detailed history of N Verses Capital, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 2,600 shares of AMPH stock, worth $98,279. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,600
Previous 2,200 18.18%
Holding current value
$98,279
Previous $88 Million 43.38%
% of portfolio
0.06%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$36.99 - $50.09 $14,796 - $20,036
400 Added 18.18%
2,600 $126 Million
Q2 2024

Jul 31, 2024

BUY
$38.65 - $43.48 $23,190 - $26,087
600 Added 37.5%
2,200 $88 Million
Q1 2024

Apr 25, 2024

BUY
$42.85 - $63.45 $68,560 - $101,520
1,600 New
1,600 $70.3 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.85B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.